Mirati Therapeutics, Inc. MRTX
58.70 0.00 (+0.00%)
At closeJan 22, 2024, 4:00 PM EST
58.54 Day range 58.99
52-week range unavailable
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 12.44M | 72.09M | 13.40M | 3.33M | 12.93M | |
| 11.84M | 72.09M | 13.40M | 3.33M | 12.93M | |
| -759.59M | -573.18M | -369.36M | -222.10M | -102.63M | |
| -740.87M | -581.78M | -357.94M | -213.26M | -98.42M | |
| -13.18 | -11.21 | -7.96 | -5.69 | -3.19 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 235.26M | 413.08M | 885.56M | 46.53M | 32.69M | |
| 1.20B | 1.59B | 1.48B | 432.20M | 228.45M | |
| 206.13M | 191.72M | 115.34M | 49.91M | 26.88M | |
| 43.66M | 45.88M | 41.91M | 0 | 0 | |
| 996.52M | 1.40B | 1.36B | 382.30M | 201.58M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -570.57M | -388.80M | -271.53M | -147.73M | -70.10M | |
| 225.80M | -588.90M | -139.86M | -176.14M | -145.76M | |
| 166.94M | 505.22M | 1.25B | 338.03M | 140.85M | |
| -4.85M | -9.79M | -4.37M | -1.55M | -122.00K | |
| -177.82M | -472.48M | 839.33M | 14.16M | -75.01M |